Action brought on 8 November 2013 – Shire Pharmaceutical Contracts v Commission
(Case T-583/13)
Language of the case: English
Parties
Applicant: Shire Pharmaceutical Contracts (Hampshire, United Kingdom) (represented by: K. Bacon, Barrister, M. Utges Manley and M. Vickers, Solicitors)
Defendant: European Commission
Form of order sought
The applicant claims that the Court should:
Annul the decision contained in the letter of the European Commission dated 2 September 2013, confirmed by the letter dated 18 October 2013, refusing eligibility for a reward for a voluntary pediatric investigation plan under Article 37 of Regulation (EC) No 1901/20061 ; and
Order the defendant to bear the applicant’s costs.
Pleas in law and main arguments
In support of the action, the applicant relies on two pleas in law.
First plea in law, alleging that the contested decision is vitiated by fundamental errors in law in the interpretation of Regulation (EC) No 1901/2006.
Second plea in law, alleging a breach of the principle of legal certainty.
________________________1 Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (OJ 2006 L 378, p. 1)